Brought to you by 
Segulah buys Medivir's CCS AB skin care business
25 Aug 2003
Executive Summary
To focus on its polymerase and protease research strategy, Medivir has divested its production-driven skin care products division Clean Chemical Sweden AB to Segulah, a Swedish private equity company.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- OTC, Consumer
-
Medical Devices
- Consumables, Central Supplies
Deal Status
- Final
Deal Type
-
Acquisition
- Buy-out
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Segulah buys Medivir's CCS AB skin care business
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice